(Q42050311)

English

Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma

scientific article published on October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

1 reference

based on heuristic

inferred from title

fluticasone propionate

1 reference

based on heuristic

inferred from title

author name string

S Sheikh

1

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

L J Goldsmith

2

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

L Howell

3

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

N Eid

4

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

300-304

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Anti-inflammatory therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new approach to the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of maintenance theophylline in steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Need for theophylline in severe steroid-requiring asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Flunisolide metabolism and dynamics of a metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962669-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62669-5

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42050311&oldid=1932665640"